Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Doi
Yohei
Y
Adams-Haduch
Jennifer M
JM
Paterson
David L
DL
D000553:Ambulatory Care; D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000382:microbiology; D029968:Escherichia coli Proteins / Q000235:genetics; D005260:Female; D006801:Humans; D008780:Methyltransferases / Q000096:biosynthesis / Q000235:genetics; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010957:Plasmids; D012336:RNA, Ribosomal, 16S; D017422:Sequence Analysis, DNA; D014481:United States; D001618:beta-Lactamases / Q000096:biosynthesis / Q000235:genetics
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D029968:Escherichia coli Proteins; D012336:RNA, Ribosomal, 16S; D008780:Methyltransferases; D001618:beta-Lactamases